BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34319852)

  • 1. HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients.
    Abdul Razzaq EA; Venkatachalam T; Bajbouj K; Rahmani M; Mahdami A; Rawat S; Mansuri N; Alhashemi H; Hamoudi RA; Bendardaf R
    Libyan J Med; 2021 Dec; 16(1):1955462. PubMed ID: 34319852
    [No Abstract]   [Full Text] [Related]  

  • 2. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
    Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
    Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer.
    Zhou FF; Huang R; Jiang J; Zeng XH; Zou SQ
    Saudi J Gastroenterol; 2018; 24(5):301-306. PubMed ID: 29873317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
    Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
    Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
    BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population.
    Ni S; Wang X; Chang J; Sun H; Weng W; Wang X; Tan C; Zhang M; Wang L; Huang Z; Huang D; Xu M; Sheng W
    Front Oncol; 2022; 12():842787. PubMed ID: 35574415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 positivity as a biomarker for poor prognosis and unresponsiveness to anti-EGFR therapy in colorectal cancer.
    Huang W; Chen Y; Chang W; Ren L; Tang W; Zheng P; Wu Q; Liu T; Liu Y; Wei Y; Xu J
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):993-1002. PubMed ID: 34156520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.
    Richman SD; Southward K; Chambers P; Cross D; Barrett J; Hemmings G; Taylor M; Wood H; Hutchins G; Foster JM; Oumie A; Spink KG; Brown SR; Jones M; Kerr D; Handley K; Gray R; Seymour M; Quirke P
    J Pathol; 2016 Mar; 238(4):562-70. PubMed ID: 26690310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HER2 in colorectal cancer does not correlate with prognosis.
    Kruszewski WJ; Rzepko R; Ciesielski M; Szefel J; Zieliński J; Szajewski M; Jasiński W; Kawecki K; Wojtacki J
    Dis Markers; 2010; 29(5):207-12. PubMed ID: 21206005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
    Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
    World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
    Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.
    Hedner C; Tran L; Borg D; Nodin B; Jirström K; Eberhard J
    Histopathology; 2016 Jan; 68(2):230-40. PubMed ID: 26016514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
    Yao YF; Du CZ; Chen N; Chen P; Gu J
    Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer.
    Singh H; Kang A; Bloudek L; Hsu LI; Corinna Palanca-Wessels M; Stecher M; Siadak M; Ng K
    JNCI Cancer Spectr; 2024 Jan; 8(1):. PubMed ID: 37815820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.
    Shi H; Shao Y; Lu W; Lu B
    J Pathol Clin Res; 2021 Jan; 7(1):86-95. PubMed ID: 33089969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.
    Seo AN; Kwak Y; Kim WH; Kim DW; Kang SB; Choe G; Lee HS
    Virchows Arch; 2015 Jun; 466(6):645-54. PubMed ID: 25739551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance and diagnostic accuracy of HER2 immunohistochemistry in colorectal cancer: a meta-analysis.
    Pyo JS; Kang G; Park K
    Int J Biol Markers; 2016 Dec; 31(4):e389-e394. PubMed ID: 27102863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India.
    Nadaf AS; Rani H; Dinesh US
    Asian Pac J Cancer Prev; 2018 May; 19(5):1381-1385. PubMed ID: 29802704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.